Yet another closing high on the S&P. Indeed, that is the end of regulation.

The Little St. Nick Foundation ringing the closing bell at the New York Stock Exchange.

Granite shares ETFs doing the honors at the NASDAQ.

Stocks continue to trickle higher into the holidays.

The fourth straight day of gains for the major averages following a stronger than expected GDP report.

The Dow with a small gain, the S&P 500 up less than half a percent, but this will likely

be a new all-time closing high.

The NASDAQ, the top performer today, losses, however, for the Russell 2000.

Communication services and tech among the best performing groups, a little bit of weakness in

healthcare and consumer staples today. But one health care name is standing out. Novo Nordis

getting approval for a pill for Wagovi for weight loss, giving it a first mover advantage over

Lilly in the race to get the oral form of these drugs instead of injections.

That's the scorecard on Wall Street.

Welcome to closing bell over time.

I'm Leslie Picker, John Ford, and Morgan Brennan are off today.

And two of today's biggest stories colliding the weight loss drug approval and the GDP,

healthcare spending one of the big drivers of GDP, of course, but will increase access to

these drugs make people healthier and bring costs down. We'll talk to Dr. Ashish Jha, outgoing

dean of Brown University's School of Public Health, and tech and communication services are the

best sectors this year, driven by AI, of course, but industrials, they're in third place,

and AI also a big driver here. The top two names in that group, driven by AI, of course, but industrials, they're in third place. An AI also a big driver here.

The top two names in that group, Comfort Systems and GEVernova, also benefiting from

...